---
title: "OptiBiotix Health (OPTI) news: IPO and offering"
url: "https://aibio.space/companies/optibiotix-health/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "OPTI IPO, offering and convertible notes news: Optimi Health prices US IPO of 2,400,000 shares at US$6.25. OptiBiotix Health PLC (LSE: OPTI), United Kingdom."
---

OPTI OptiBiotix Health PLC LSE · United Kingdom

# OptiBiotix Health (OPTI) news OPTI IPO, offering and convertible notes news

Financings · 2026-08-27

## [Optimi Health sets up equity line to sell up to US$100 million of shares to Seven Knots](https://aibio.space/news/optimi-health-sets-up-equity-line-sell-up-us-100-million-shares-seven/)

Optimi can sell shares to Seven Knots, LLC at its discretion, up to US$2 million per draw. It issued a US$1.5 million convertible note as a commitment fee.

## Latest OptiBiotix Health news

1. 2026-05-20 Financings [Optimi Health prices US IPO of 2,400,000 shares at US$6.25](https://aibio.space/news/optimi-health-prices-us-ipo-2-400-000-shares-us-6-25/) The offering totals US$15,000,000 before fees. Optimi has been approved to list on the Nasdaq Capital Market under the symbol OPTH.
2. 2025-09-05 Financings [Optimi Health files for U.S. IPO and Nasdaq uplisting from Canadian exchange](https://aibio.space/news/optimi-health-files-u-s-ipo-nasdaq-uplisting-canadian-exchange/) The British Columbia company plans a reverse share split and has applied to list on the Nasdaq Capital Market. Titan Partners Group is the sole bookrunner.

## OptiBiotix Health at a glance

- **Ticker**: OPTI

- **Listing**: LSE

- **Country**: United Kingdom

### Related companies

- [OKYO Pharma](https://aibio.space/companies/okyo-pharma/) NASDAQ: OKYO
- [Vidac Pharma Holding Plc](https://aibio.space/companies/vidac-pharma/) XETR: T9G
- [Scancell Holdings Plc](https://aibio.space/companies/scancell/) LSE: SCLP
- [Mereo BioPharma Group](https://aibio.space/companies/mereo-biopharma/) NASDAQ: MREO
- [Adaptimmune Therapeutics](https://aibio.space/companies/adaptimmune-therapeutics/) OTC: ADAPY
- [COMPASS Pathways Plc](https://aibio.space/companies/compass-pathways/) NASDAQ: CMPS
- [Nuformix Plc](https://aibio.space/companies/nuformix/) LSE: NFX
- [Genflow Biosciences Plc](https://aibio.space/companies/genflow-biosciences/) LSE: GENF

### Also on LSE

- [Nuformix Plc](https://aibio.space/companies/nuformix/) NFX
- [PureTech Health](https://aibio.space/companies/puretech-health/) PRTC
- [Diaceutics Plc](https://aibio.space/companies/diaceutics/) DXRX
- [GSK](https://aibio.space/companies/gsk/) GSK
- [Oxford BioDynamics Plc](https://aibio.space/companies/oxford-biodynamics/) OBD
- [Bioventix Plc](https://aibio.space/companies/bioventix/) BVXP

## Questions about OptiBiotix Health

When did OptiBiotix Health go public?

Our latest story on this, dated May 20, 2026: "Optimi Health prices US IPO of 2,400,000 shares at US$6.25". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/optimi-health-prices-us-ipo-2-400-000-shares-us-6-25/).

Has OptiBiotix Health raised money recently?

Our latest story on this, dated May 20, 2026: "Optimi Health prices US IPO of 2,400,000 shares at US$6.25". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/optimi-health-prices-us-ipo-2-400-000-shares-us-6-25/).

Has OptiBiotix Health sold convertible notes?

Our latest story on this, dated Aug 27, 2026: "Optimi Health sets up equity line to sell up to US$100 million of shares to Seven Knots". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/optimi-health-sets-up-equity-line-sell-up-us-100-million-shares-seven/).

What is the ticker symbol of OptiBiotix Health?

OptiBiotix Health PLC trades under the ticker OPTI on LSE.

Where is OptiBiotix Health listed?

OptiBiotix Health PLC is listed on LSE.

Which country or territory is OptiBiotix Health listed under?

Our directory records OptiBiotix Health PLC under United Kingdom.

What does OptiBiotix Health do?

Our directory classifies OptiBiotix Health PLC as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of OptiBiotix Health?

The ISIN recorded for OptiBiotix Health PLC is GB00BP0RTP38.

Does aibio.space cover OptiBiotix Health?

aibio.space lists OptiBiotix Health PLC among 2,820 public biotech companies and publishes its news here as stories appear.

What is the latest OptiBiotix Health (OPTI) stock news?

Our latest story on OptiBiotix Health, dated Aug 27, 2026: "Optimi Health sets up equity line to sell up to US$100 million of shares to Seven Knots". Optimi can sell shares to Seven Knots, LLC at its discretion, up to US$2 million per draw. It issued a US$1.5 million convertible note as a commitment fee. [Source](https://aibio.space/news/optimi-health-sets-up-equity-line-sell-up-us-100-million-shares-seven/).

How long will OptiBiotix Health's cash last?

From our story of May 20, 2026: The prospectus says the company has suffered recurring losses and has a net capital deficiency, and that these conditions raise substantial doubt about its ability to continue as a going concern. [Source](https://aibio.space/news/optimi-health-prices-us-ipo-2-400-000-shares-us-6-25/).

Which companies are similar to OptiBiotix Health?

Companies in our directory listed in the same country and business area as OptiBiotix Health: OKYO Pharma, Vidac Pharma Holding Plc, Scancell Holdings Plc, Mereo BioPharma Group, Adaptimmune Therapeutics, COMPASS Pathways Plc.

How can I follow OptiBiotix Health (OPTI) news?

Press Follow on this page to add OptiBiotix Health to your Following list, or subscribe to the aibio.space newsletter. We have published 3 stories naming OptiBiotix Health so far, in Financings.

## Investor discussion: OptiBiotix Health

Members talk about OptiBiotix Health (OPTI). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at OptiBiotix Health, newest first. Each line links the filing it comes from.

1. 2026-08-27 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/2027329/000117184326005754/exh_991.htm)
2. 2026-08-14 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/2027329/000117184326005554/exh_991.htm)
3. 2026-08-14 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/2027329/000121390026090286/ea030225801ex99-1.htm)
4. 2026-06-02 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/2027329/000119312526251855/d119379dex991.htm)
5. 2026-05-20 Financings Filed a final prospectus for a securities offering. SEC Form 424B4. [Source](https://www.sec.gov/Archives/edgar/data/2027329/000119312526231760/d43258d424b4.htm)
6. 2025-09-05 Financings Filed a registration statement for a share offering. SEC Form F-1. [Source](https://www.sec.gov/Archives/edgar/data/2027329/000119312525197327/d81568df1.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open LSE:OPTI on TradingView](https://www.tradingview.com/symbols/LSE-OPTI/).

## Listing details

OptiBiotix Health PLC is a public biotech or pharmaceutical company listed on LSE under the ticker OPTI, recorded under United Kingdom. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: OptiBiotix Health PLC

- **Ticker**: OPTI

- **Listing**: LSE

- **Country or territory**: United Kingdom

- **Business scope**: Biotechnology

- **ISIN**: GB00BP0RTP38

- **Last quote in directory**: 2026-10-22

- **Directory source**: [Listing page](https://www.tradingview.com/symbols/LSE-OPTI/)

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/optibiotix-health/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "OptiBiotix Health (OPTI) news: IPO and offering", 2026-10-31, https://aibio.space/companies/optibiotix-health/
